Adverse Event reporting information can be found in footer

Request a Meeting

Welcome to Ferring Urology

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.
Ferring has over 50 years’ experience in Urology and our main focus is on Uro-Oncology, currently specialising in the treatment of prostate cancer. Ferring also provides treatments for nocturnal enuresis and nocturia.

Products

DesmoMelt is a sublingual oral lyophilisate formulation of desmopressin which is indicated for the treatment of primary nocturnal enuresis in children and adults aged 5 to 65.1
READ MORE➔
P.I.

New license indication:

Firmagon® is a gonadotrophin releasing hormone (GnRH) antagonist indicated for the treatment of adult male patients with advanced hormone-dependent prostate cancer in the UK, also in combination with radiotherapy and as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone-dependent prostate cancer 2,3

READ MORE➔
P.I.

Noqdirna is a low-dose desmopressin melt formulation – the only licensed treatment for idiopathic nocturnal polyuria in adults (including the over 65s).3
READ MORE➔
P.I.
  1. DesmoMelt Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/17268. Date accessed: May 2023.
  2. Firmagon® 120mg injection. Summary of Product Characteristics. Ferring Pharmaceuticals Limited. October 2022. Available at: https://www.medicines.org.uk/emc/product/6537 (Last Accessed March 2023)
  3. Firmagon® 80mg injection. Summary of Product Characteristics. Ferring Pharmaceuticals Limited. October 2022. Available at: https://www.medicines.org.uk/emc/product/6535 (Last Accessed March 2023)
  4. Noqdirna Summary of Product Characteristics. Available at: http://www.medicines.org.uk/emc/medicine/32493. Date accessed: May 2023.

Job Code: UK-FN-2300010 - Date of preparation: May 2023

cookiepopup

Our use of cookies

We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.

Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.